Literature DB >> 8932802

Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.

F Locatelli1, M Zecca, C Niemeyer, E Angelucci, G Arcese, C Bender-Gotze, F Bonetti, S Burdach, G Dini, W Ebell, W Friedrich, H Hasle, J Hermann, N Jacobsen, T Klingebiel, B Kremens, G Mann, R Miniero, A Pession, C Peters, P Paolucci, F Rossetti, H J Schmid, J Stary, M Zimmermann.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8932802

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet disease.

Authors:  Kazumi Yamato
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

2.  Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.

Authors:  A B M Madureira; M Eapen; F Locatelli; P Teira; M-J Zhang; S M Davies; A Picardi; A Woolfrey; K-W Chan; G Socié; A Vora; Y Bertrand; C M Sales-Bonfim; E Gluckman; C Niemeyer; V Rocha
Journal:  Leukemia       Date:  2010-12-07       Impact factor: 11.528

3.  CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies.

Authors:  Yixin Hu; Kenneth J Caldwell; Mihaela Onciu; Sara M Federico; Marta Salek; Sara Lewis; Shaohua Lei; Jinghui Zhang; Kim E Nichols; Clifford M Takemoto; Brandon M Triplett; Jason E Farrar; Jeffrey E Rubnitz; Raul C Ribeiro; Marcin W Wlodarski
Journal:  Blood Adv       Date:  2022-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.